Related Experiment Video
Updated: Apr 6, 2026

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis
Published on: February 24, 2023
Rapid Cavitary Pneumonia and Reversible Hepatic Injury in Burkholderia pseudomallei ST271 Infection
Nan Zhang1, Liang Li2, Fang Chen1
1NHC Key Laboratory of Tropical Disease Control, School of Life Sciences and Medical Technology, Hainan Medical University, Haikou, Hainan, China.
Abstract:
BACKGROUND Burkholderia pseudomallei is the causative agent of melioidosis, an infectious disease endemic to tropical and subtropical regions that displays highly variable clinical presentations, ranging from localized abscesses to severe septicemia. Sequence type (ST) 271 has been rarely reported; data concerning its clinical and epidemiological characteristics remain limited. This report describes a rare case of ST271 infection presenting with rapidly progressive cavitary pneumonia and reversible hepatic injury. CASE REPORT A previously healthy 50-year-old male construction worker from Haikou, China, presented with a 2-week history of intermittent fever, hemoptysis, and persistent cough. Chest computed tomography revealed a thick-walled cavitary mass in the right upper lobe. Laboratory findings demonstrated substantially elevated liver enzymes, indicating acute hepatic injury. Metagenomic sequencing of bronchoalveolar lavage fluid identified B. pseudomallei, and whole-genome sequencing classified the isolate as ST271. The strain was sensitive to imipenem, ceftazidime, and trimethoprim-sulfamethoxazole; preliminary in vitro bacteriophage susceptibility also was observed. After initiation of intravenous ceftazidime followed by oral trimethoprim-sulfamethoxazole, the patient showed rapid clinical improvement that included robust resolution of the pulmonary lesion and normalization of liver enzymes, consistent with reversible hepatic injury. CONCLUSIONS This case highlights the aggressive clinical course of the rare B. pseudomallei ST271 strain, characterized by rapidly progressive cavitary pneumonia and concurrent hepatic injury in an immunocompetent host. Early identification using sequencing techniques facilitated timely targeted therapy and a favorable recovery. The observed in vitro phage susceptibility may provide preliminary insight for future research into alternative management strategies for resistant strains.
Insights
A rare Burkholderia pseudomallei ST271 infection caused severe pneumonia and liver injury in an immunocompetent patient. Early sequencing and targeted therapy led to a full recovery, suggesting potential for phage therapy.
Area of Science:
- Infectious Diseases
- Genomics
- Pulmonology
Background:
- Melioidosis, caused by Burkholderia pseudomallei, presents with diverse clinical manifestations.
- Sequence type (ST) 271 of B. pseudomallei is infrequently documented, with limited clinical and epidemiological data.
- This case report details a rare instance of ST271 infection.
Purpose of the Study:
- To describe a rare case of B. pseudomallei ST271 infection.
- To highlight the clinical and epidemiological characteristics of this rare strain.
- To emphasize the role of early diagnostics and treatment.
Main Methods:
- Case report of a previously healthy 50-year-old male.
- Chest CT imaging for pulmonary assessment.
- Metagenomic and whole-genome sequencing of bronchoalveolar lavage fluid for pathogen identification and strain typing.
- Antimicrobial susceptibility testing and preliminary bacteriophage susceptibility testing.
Main Results:
- The patient presented with rapidly progressive cavitary pneumonia and acute hepatic injury.
- B. pseudomallei ST271 was identified as the causative agent.
- The strain exhibited sensitivity to imipenem, ceftazidime, and trimethoprim-sulfamethoxazole, with observed in vitro bacteriophage susceptibility.
- The patient experienced rapid clinical improvement and resolution of symptoms following targeted antibiotic therapy.
Conclusions:
- The rare B. pseudomallei ST271 strain can cause aggressive cavitary pneumonia and hepatic injury in immunocompetent individuals.
- Early identification via sequencing is crucial for timely and effective treatment.
- Successful treatment with ceftazidime and trimethoprim-sulfamethoxazole was achieved.
- In vitro bacteriophage susceptibility suggests potential for novel therapeutic strategies against B. pseudomallei.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Viral Meningitis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Atypical Pneumonia
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

